Codeine, guaifenesin, pseudoephedrine, triprolidine
Sold as Colzor adult, Adco-neofed paediatric, Neofed adult, Colzor paediatric, Dinexol paediatric cough, Trifen expect paediatric, Trifen expect adult, Flusin junior cough, Flutex antitussive, Zurituss adult, Zurituss paediatric, Tripofed paediatric, Tripofed adult, Endcol paediatric expectorant, Endcol expectorant, Acutussive adult expect, Acutussive paed expect, Innospect adult, Innospect paed
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 6
- Registrations
- 19
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Adcock ingram limited4 of 6 cancelled | Colzor adult, Adco-neofed paediatric, Neofed adult, Colzor paediatric, Zurituss adult, Zurituss paediatric | Not stated | 270436, 270485, 270486, 270487, 280537, 280538 | Not determined | None |
| Pharmacare limited û woodmeadCertificate held by Pharmacare limited2 of 5 cancelled | Dinexol paediatric cough, Flusin junior cough, Flutex antitussive, Endcol paediatric expectorant, Endcol expectorant | syrup, 1 g, 5 mg | 270530, 280433, 280434, T0255, U0011 | Not determined | PIPIL |
| Ranbaxy (SA) (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) Ltd | Trifen expect paediatric, Trifen expect adult | 5 mg/5 ml, 5 ml | 270536, 270537 | S2 | PIPIL |
| Viatris South Africa (Pty) Ltd | Tripofed paediatric, Tripofed adult | Not stated | 280681, 290447 | Not determined | None |
| Teva Pharmaceuticals (Pty) LtdCancelled | Acutussive adult expect, Acutussive paed expect | Not stated | X0010, X0011 | Not determined | None |
| Innovata pharmaceuticals | Innospect adult, Innospect paed | Not stated | Y0139, Y0140 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Colzor adult EACH 5 ml SOLUTION CONTAINS CODEINE PHOSPHATE 7,5 mg GUAIFENESIN 100 mg PSEUDOEPHEDRINE HYDROCHLORIDE 20 mg TRIPROLIDINE HYDROCHLORIDE 1,25 mg | Not listed | 27043627/10.1/0436 | Registered | Not determined | None |
| Adco-neofed paediatric EACH 5,0 ml SOLUTION CONTAINS CODEINE PHOSPHATE 3,0 mg GUAIFENESIN 50,0 mg PSEUDOEPHEDRINE HYDROCHLORIDE 12,0 mg TRIPROLIDINE HYDROCHLORIDE 0,6 mg | Not listed | 27048527/10.1/0485 | Cancelled | Not determined | None |
| Neofed adult EACH 5 ml SOLUTION CONTAINS CODEINE PHOSPHATE 7,5 mg GUAIFENESIN 100 mg PSEUDOEPHEDRINE HYDROCHLORIDE 20 mg TRIPROLIDINE HYDROCHLORIDE 1,25 mg | Not listed | 27048627/10.1/0486 | Registered | Not determined | None |
| Colzor paediatric EACH 5 ml SOLUTION CONTAINS CODEINE PHOSPHATE 3 mg GUAIFENESIN 50 mg PSEUDOEPHEDRINE HYDROCHLORIDE 12 mg TRIPROLIDINE HYDROCHLORIDE 0,6 mg | Not listed | 27048727/10.1/0487 | Cancelled | Not determined | None |
| Dinexol paediatric cough syrup EACH 5 ml SYRUP CONTAINS CODEINE PHOSPHATE 3 mg GUAIFENESIN 50 mg PSEUDOEPHEDRINE HYDROCHLORIDE 12 mg TRIPROLIDINE HYDROCHLORIDE 0,6 mg | Syrup | 27053027/10.1/0530 | Cancelled | Not determined | None |
| Trifen expect paediatric EACH 5 mL SOLUTION CONTAINS CODEINE PHOSPHATE 3 mg GUAIFENESIN 50 mg PSEUDOEPHEDRINE HYDROCHLORIDE 12 mg TRIPROLIDINE HYDROCHLORIDE 0,6 mg | 5 mg/5 mlSolution | 27053627/10.1/0536Approved 24 May 2024 | Registered | S2 | PIPIL |
| Trifen expect adult EACH 5 mL SOLUTION CONTAINS CODEINE PHOSPHATE 7,5 mg GUAIFENESIN 100 mg PSEUDOEPHEDRINE HYDROCHLORIDE 20 mg TRIPROLIDINE HYDROCHLORIDE 1,25 mg | 5 mlSolution | 27053727/10.1/0537Approved 24 May 2024 | Registered | S2 | PIPIL |
| Flusin junior cough syrup EACH 5 ml SOLUTION CONTAINS CODEINE PHOSPHATE 3 mg GUAIFENESIN 50 mg PSEUDOEPHEDRINE HYDROCHLORIDE 12 mg TRIPROLIDINE HYDROCHLORIDE 0,6 mg | 1 g. 5 mgSyrup | 28043328/10.1/0433Approved 7 May 2021 | Registered | Not determined | PIPIL |
| Flutex antitussive EACH 5 ml SYRUP CONTAINS CODEINE PHOSPHATE 7,5 mg GUAIFENESIN 100 mg PSEUDOEPHEDRINE HYDROCHLORIDE 20 mg TRIPROLIDINE HYDROCHLORIDE 1,25 mg | Not listed | 28043428/10.1/0434 | Registered | Not determined | None |
| Zurituss adult EACH 5 ml SOLUTION CONTAINS CODEINE PHOSPHATE 7,5 mg GUAIFENESIN 100 mg PSEUDOEPHEDRINE HYDROCHLORIDE 20 mg TRIPROLIDINE HYDROCHLORIDE 1,25 mg | Not listed | 28053728/10.1/0537 | Cancelled | Not determined | None |
| Zurituss paediatric EACH 5 ml SOLUION CONTAINS CODEINE PHOSPHATE 3 mg GUAIFENESIN 50 mg PSEUDOEPHEDRINE HYDROCHLORIDE 12 mg TRIPROLIDINE HYDROCHLORIDE 0,6 mg | Not listed | 28053828/10.1/0538 | Cancelled | Not determined | None |
| Tripofed paediatric EACH 5 ML SOLUTION CONTAINS CODEINE PHOSPHATE 3 MG GUAIFENESIN 50 MG PSEUDOEPHEDRINE HYDROCHLORIDE 12 MG TRIPROLIDINE HYDROCHLORIDE 0,6 MG | Not listed | 28068128/10.1/0681 | Registered | Not determined | None |
| Tripofed adult EACH 5 ML SOLUTION CONTAINS CODEINE PHOSPHATE 7,5 MG GUAIFENESIN 100 MG PSEUDOEPHEDRINE HYDROCHLORIDE 20 MG TRIPROLIDINE HYDROCHLORIDE 1,25 MG | Not listed | 29044729/10.1/0447 | Registered | Not determined | None |
| Endcol paediatric expectorant EACH 5 ml SYRUP CONTAINS CODEINE PHOSPHATE 3,0 mg GUAIFENESIN 50,0 mg PSEUDOEPHEDRINE HYDROCHLORIDE 12,0 mg TRIPROLIDINE HYDROCHLORIDE 0,6 mg | Not listed | T0255T/10.1/255 | Cancelled | Not determined | None |
| Endcol expectorant EACH 5 ML CONTAINS CODEINE PHOSPHATE 7,5 MG GUAIFENESIN 100 MG PSEUDOEPHEDRINE HYDROCHLORIDE 20 MG TRIPROLIDINE HYDROCHLORIDE 1,25 MG | Not listed | U0011U/10.1/11 | Registered | Not determined | None |
| Acutussive adult expect EACH 5 ml SOLUTION CONTAINS CODEINE PHOSPHATE 7,5 mg GUAIFENESIN 100 mg PSEUDOEPHEDRINE HYDROCHLORIDE 20 mg TRIPROLIDINE HYDROCHLORIDE 1,25 mg | Not listed | X0010X/10.1/10 | Cancelled | Not determined | None |
| Acutussive paed expect EACH 5 ml SOLUTION CONTAINS CODEINE PHOSPHATE 3 mg GUAIFENESIN 50 mg PSEUDOEPHEDRINE HYDROCHLORIDE 12 mg TRIPROLIDINE HYDROCHLORIDE 0,6 mg | Not listed | X0011X/10.1/11 | Cancelled | Not determined | None |
| Innospect adult EACH 5 ml SYRUP CONTAINS CODEINE PHOSPHATE 7,5 mg GUAIFENESIN 100 mg PSEUDOEPHEDRINE HYDROCHLORIDE 20 mg TRIPROLIDINE HYDROCHLORIDE 1,25 mg | Not listed | Y0139Y/10.1/139 | Registered | Not determined | None |
| Innospect paed EACH 5 ml SYRUP CONTAINS CODEINE PHOSPHATE 3 mg GUAIFENESIN 50 mg PSEUDOEPHEDRINE HYDROCHLORIDE 12 mg TRIPROLIDINE HYDROCHLORIDE 0,60 mg | Not listed | Y0140Y/10.1/140 | Registered | Not determined | None |
Regulatory status
Where S2 sits on the scale
A pharmacist can sell it directly, without a prescription.
Schedule 2 medicines sit behind the pharmacy counter. A pharmacist can decide to sell one of these directly, using their own professional judgement, without a doctor's prescription. It can also be dispensed against a prescription like the higher tiers, in which case the usual repeat limits apply. A child under 12 may only be sold a Schedule 2 substance on a prescription, or on a written order that names the purpose and carries a signature the seller recognises. Even though it cannot be advertised to the public in the ordinary sense, its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S2, read from the product's PI-PIL leaflet.
Who may supply: Only a pharmacist, pharmacist intern or supervised pharmacist's assistant may sell it without a prescription. It may otherwise be dispensed by a pharmacist against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Trifen expect paediatric, Ranbaxy (SA) (Pty) Ltd is scheduled S2 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.